Literature DB >> 18467109

Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.

Qiang Wang1, Maoying Chen, Huawei Zhu, Jie Zhang, Hao Fang, Binghe Wang, Wenfang Xu.   

Abstract

A series of novel l-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N (APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC(50)=13.2microM) similar with APN inhibitor Bestatin (IC(50)=15.5microM), and could be used as lead compound in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467109     DOI: 10.1016/j.bmc.2008.04.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.

Authors:  Xuejian Wang; Fanbo Jing; Huawei Zhu; Hao Fang; Jian Zhang; Wenfang Xu
Journal:  Fundam Clin Pharmacol       Date:  2011-04       Impact factor: 2.748

2.  Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.

Authors:  Kanghui Yang; Qiang Wang; Li Su; Hao Fang; Xuejian Wang; Jianzhi Gong; Binghe Wang; Wenfang Xu
Journal:  Bioorg Med Chem       Date:  2009-04-24       Impact factor: 3.641

3.  Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.

Authors:  Jiajia Mou; Hao Fang; Fanbo Jing; Qiang Wang; Yingzi Liu; Huawei Zhu; Luqing Shang; Xuejian Wang; Wenfang Xu
Journal:  Bioorg Med Chem       Date:  2009-05-03       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.